• β-Elemene Assay Workflows for AMPK Research

  2026-09-30

  Use β-Elemene as a practical probe for adipocyte differentiation, insulin-resistance phenotypes, and AMPK-linked metabolic signaling. The same compound also supports carefully bounded extensions into neuroprotection, inflammation, cancer biology, and analytical standardization.

• HHV-7 DNA in Ocular Toxoplasmosis

  2026-09-30

  This case report describes the first, to the authors’ knowledge, detection of human herpesvirus 7 DNA in vitreous humor from an eye with recurrent ocular toxoplasmosis. Co-detection of Toxoplasma gondii and HHV-7 during refractory uveitis, followed by clinical resolution and loss of detectable DNA after treatment, supports a hypothesis of HHV-7 reactivation but does not establish causality.

• Nifedipine: A Calcium Lens on Liver Translation

  2026-09-29

  Nifedipine (BAY-a-1040) offers translational researchers a controlled way to test how L-type calcium influx shapes liver metabolism, iron handling, and disease-relevant phenotypes. By pairing calcium perturbation with PXR, CYP, viability, and transporter readouts, researchers can move beyond descriptive product testing toward mechanistically resolved models.

• Chloroquine BA1002: Practical Assay Guide

  2026-09-29

  Chloroquine BA1002 provides a defined 4-aminoquinoline perturbagen for lysosomal pH, autophagy, inflammatory signaling, malaria, and cell-response assays. This guide explains solvent handling, concentration selection, controls, and interpretation limits; it should not be used as a substitute for clinical dosing guidance or as proof of pathway-specific activity.

• DDI2–NFE2L1 Protects Cells from Ferroptosis

  2026-09-28

  The reference study identifies DDI2-mediated activation of NFE2L1 as an adaptive proteostasis response to ferroptosis. By combining ubiquitylation profiling, genetic perturbation, proteasome measurements, and pharmacological testing, it shows that disabling this pathway increases proteasome failure and ferroptotic cell death.

• ISRIB and the Biology of Accelerated Forgetting

  2026-09-28

  ISRIB (trans-isomer) offers translational researchers a way to probe how integrated stress response signaling shapes memory retention—not just memory formation. A recent mouse study links inflammation-associated accelerated forgetting to hippocampal ISR activation, while highlighting why target engagement, treatment timing, and behavioral controls matter.

• Cell Death Mechanisms in Liver Disease

  2026-09-27

  Luedde, Kaplowitz, and Schwabe synthesize evidence that hepatocyte death is not merely a marker of liver injury: its mode and context shape inflammation, fibrosis, cirrhosis, and liver cancer. Their review connects clinical biomarkers with cell-death mechanisms and highlights why therapeutic strategies must account for the responding cell type and disease stage.

• Methotrexate Workflows for DHFR and T-Cell Studies

  2026-09-26

  Use Methotrexate to probe DHFR-dependent proliferation, activated T-cell responses, and anti-inflammatory mechanisms—with a concentration-and-time workflow designed to separate growth inhibition from apoptosis. A recent membrane-chromatography comparison also offers practical guidance for choosing permeability assays, while making clear that its findings do not establish Methotrexate-specific pulmonary transport.

• Dexamethasone (DHAP): From Mechanism to Model

  2026-09-25

  Dexamethasone is more than an anti-inflammatory benchmark: its effects vary across immune, neural, stem-cell, and tumor models. This guide connects mechanism to model choice, assay design, and translational interpretation.

• BIIE 0246: Selective Neuropeptide Y Y2 Antagonist

  2026-09-25

  BIIE 0246 is a potent, selective neuropeptide Y Y2 receptor antagonist used to investigate Y2R signaling in neural, gastrointestinal, and feeding-behavior models. Its reported pharmacology supports experimental NPY Y2 receptor inhibition, but it does not establish Y2R as a mechanism in the cited epicardial-adipose arrhythmia study, which identifies NPY signaling through Y1R.

• Imipramine Workflows for Autophagy and Apoptosis

  2026-09-24

  Use Imipramine to build controlled, dose-ranging studies of glioma-cell autophagy and HL-60 apoptosis, while keeping transporter binding potency distinct from cellular response. The workflow combines practical handling guidance with assay controls and a carefully bounded connection to recent ceramide lipidomics in fish nodavirus research.

• Early Adversity Disrupts Innate Defense via Oxytocin

  2026-09-24

  A 2026 mouse study reports that early-life social deprivation weakens defensive responses to looming visual stimuli and links this effect to reduced oxytocin-receptor expression in the superior colliculus. Circuit-level findings and partial behavioral rescue with intranasal oxytocin point to oxytocin signaling as a candidate mechanism, while leaving important questions about timing, specificity, and translation open.

• Removing Pollen Interference in EEM Bioaerosol Analysis

  2026-09-23

  Zhang and colleagues tested how pollen affects fluorescence-based classification of hazardous bioaerosol components and found that fast Fourier transform (FFT) processing improved random-forest accuracy to 89.24%. The study offers a practical signal-processing strategy for reducing spectral interference, while underscoring the need to validate models across sample types and measurement conditions.

• Platanoside, Ferroptosis, and Acute Lung Injury

  2026-09-23

  The reference study identifies an autophagy-dependent mechanism by which platanoside promotes Keap1 degradation, activates the Nrf2/GPX4 antioxidant axis, and suppresses ferroptosis in lipopolysaccharide-induced acute lung injury. Its findings connect molecular regulation of lipid peroxidation with mitochondrial and histological improvements, while also highlighting the need for validation beyond an experimental mouse model.

• Rapamycin (Sirolimus): From mTOR to Translational Insight

  2026-09-22

  Rapamycin (Sirolimus) is more than a potent mTOR perturbation tool: it provides a strategic way to connect pathway inhibition with autophagic flux, immune-cell function, cancer phenotypes, and mitochondrial disease biology. This article translates mechanistic evidence into practical experimental guidance while defining the limits of extrapolating between models.

8381 records 2/559 page Previous Next 12345 下5页 Last page